Related Experiment Video
Updated: Feb 28, 2026
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
11.3K
Bromodomain-containing proteins in prostate cancer
Alfonso Urbanucci1, Ian G Mills2
1Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, Forskningsparken, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Molecular and Cellular Endocrinology
|June 19, 2017
Summary
Bromodomain (BRD)-containing proteins, including BET family proteins, are emerging as promising therapeutic targets for prostate cancer. Targeting these proteins offers a new strategy beyond androgen receptor (AR) signaling suppression.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Prostate cancer progression involves multiple oncogenic factors, with current therapies primarily targeting androgen receptor (AR) signaling.
- Traditional drug development targeting transcription factors is challenging due to the lack of tractable binding pockets.
- Focus has shifted to transcription co-regulators, such as chromatin-modifying enzymes and epigenetic factors.
Purpose of the Study:
- To review bromodomain (BRD)-containing proteins as potential biomarkers and drug targets in prostate cancer.
- To explore the therapeutic potential of targeting BET family proteins in AR-driven cancers.
- To provide an overview of BRD-containing proteins and their role in prostate cancer.
Main Methods:
- Review of existing literature on BRD-containing proteins, BET family proteins, and their interaction with AR.
- Analysis of the role of BRD-containing proteins in chromatin modification and epigenetic regulation.
- Exploration of small molecule inhibitors targeting BET family proteins.
Main Results:
- Bromodomain (BRD)-containing proteins, particularly BET family proteins, are involved in epigenetic regulation and interact with the androgen receptor (AR).
- Small molecule inhibitors targeting BET proteins show efficacy in inactivating c-Myc in lymphoma and are being investigated for prostate cancer.
- BET family proteins represent a potential alternative strategy for targeting AR-driven prostate cancers.
Conclusions:
- BRD-containing proteins, especially BET family members, hold significant potential as novel biomarkers and therapeutic targets for prostate cancer.
- Targeting BET proteins offers a promising alternative or complementary strategy to AR signaling suppression in prostate cancer treatment.
- Further research into BRD-containing proteins could lead to the development of new drugs for AR-driven cancers.
Keywords:
Androgen receptorBRD BET bromodomain and extra-terminal domainBRD BET inhibitorChromatin structure remodelingProstate cancerTranscriptional co-activatorMore Related Videos
Related Concept Videos
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:38The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
01:23Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
01:20The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K